Below is a list of Amgen-sponsored, disclosed clinical trials.
|Study to Assess if ABP 798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab (JASMINE)||Completed|
|Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab||Completed|
|A Randomized, Double-Blind, Active-Controlled Phase 3 Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)||Recruiting|
|A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]||Not Yet Recruiting|